advertisement
Pharmaceuticals (Basel, Switzerland) 128
Showing records 1 to 25 | Display only abstracts in Pharmaceuticals (Basel, Switzerland) from IGR 22-3118649 The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods
Lejwoda K
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
117638 The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina
Rusciano D
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
117594 From Eye Care to Hair Growth: Bimatoprost
Zeppieri M; Gagliano C
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
117638 The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina
Russo C
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
118649 The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods
Gumieniczek A
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
117594 From Eye Care to Hair Growth: Bimatoprost
Spadea L
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
118649 The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods
Filip A; Naumczuk B
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
117594 From Eye Care to Hair Growth: Bimatoprost
Salati C; Chukwuyem EC; Enaholo ES; D'Esposito F; Musa M
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 24-4)
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Lindner T
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Honisch C
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Salvetat ML
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Buonfiglio F
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Rodella U
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Pfeiffer N
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Pellegrini F
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Schmidl D
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Spadea L
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Gericke A
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Peschorn L
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Gatto C; Ruzza P
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Pai V
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Salati C
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Popa-Cherecheanu A
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Tóthová JD
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Zeppieri M
Pharmaceuticals (Basel, Switzerland) 2023; 16: (IGR: 24-3)
